Oct
2026
Fiera Milano, Italy
Visit us
stand 18D1, Finished Dosage & Formulation
Replek
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:North Macedonia
-
On CPHI since:2022
-
Certificates:2
-
Employees:250 - 499
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 18D1, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product PARAFEN film coted tablets
Product: PARAFEN Ibuprofen, Paracetamol EU CTD available dossier Registered in MK PVC/PVDC blister Proposed shelf life: 3 years Storage conditions are indicated on the packaging Manufacturing: EU GMP approved manufacturing site Industrial batch size 20 800 unit box -
Product Oralsept® spray
1 ml solution contains 1.5 mg benzidamine hydrochloride.
Box with a plastic container of 30 ml spray with a dosing pump. -
Product GINOFIX®
metronidazole, clotrimazole
500 mg + 200 mg pessaries
INDICATIONS:
GINOFIX® is indicated in the treatment of vaginal infections with mixed etiology caused by: Trichomonas vaginalis, Fungi (especially Candida), Sensitive Gram-negative and Gram-p... -
Product Rekonazol shampoo
120 ml shampoo
Rekonazol® 2%
Ketoconazole
API:
Each g shampoo contains 20 mg Ketoconazole.
INDICATIONS:
Prevention and treatment of dandruff and seborrhoeic dermatitis.
Prevention and treatment of tinea (pityriasis) versicolor of... -
Product REMIG spray
Nasal spray 15 ml
Specific Natural Preventive Treatment for Migraine
Preventive therapy against migraine
Reduces both frequency and intensity of attacks
Mechanical mode of action
Rapid osmotic effect
Compatible with standard ...
Replek Resources (1)
-
Video Replek - 20 Years Anniversary
Our concept and our main goal was construction and establishment of a modern factory for production of pharmaceuticals, which was completed in 2001.
Designed, built and equipped in accordance with the latest requirements for good manufacturing practice and the most stringent requirements for environmental protection, today the factory is a modern, operational, high-standardized production capacity.
The facility can produce more than 150 drugs registered in our country and numerous foreign markets, in accordance with the strictest requirements for quality and safety of medicines.
Our future goal is continuous implementation of new technologies in operation, building new capacities, expanding the product range, increasing the number of exporting partners and achieving greater cost-effectiveness.




